Investigating effects of Evobrutinib on immune and non-immune cells in microglia-enhanced brain organoids (2023–2025)

Grant type:
Merck Group T/A Ares Trading SA
Researchers:
  • Principal Research Fellow
    UQ Centre for Clinical Research
    Faculty of Medicine
    Principal Research Fellow
    UQ Centre for Clinical Research
    Faculty of Medicine
  • Research Fellow
    UQ Centre for Clinical Research
    Faculty of Medicine
    Research Fellow
    UQ Centre for Clinical Research
    Faculty of Medicine
  • Postdoctoral Research Fellow
    UQ Centre for Clinical Research
    Faculty of Medicine
    Postdoctoral Research Fellow
    UQ Centre for Clinical Research
    Faculty of Medicine
  • Professor
    UQ Centre for Clinical Research
    Faculty of Medicine
Funded by:
Merck Group T/A Ares Trading SA